Treatment Adherence Quantitative Assessment Questionnaire Test
How the Scales are Structured
Who Usually Takes This Test?
See How You Compare
Below is a preview of how scores are typically distributed across each scale.
Example Questions From the Test
- Not important at all
- Almost not important
- Rather not important than important
- Rather important than not important
- Quite important
- Very important
- Not important at all
- Almost not important
- Rather not important than important
- Rather important than not important
- Fairly important
- Very important
- Not at all important / not applicable (no sexual activity)
- Hardly important
- More not important than important
- More important than not important
- Fairly important
- Very important
Treatment Adherence Quantitative Assessment Questionnaire Test - Description and methodology of the test
People living with a chronic condition can use the Treatment Adherence Quantitative Assessment Questionnaire Test to examine how ready they feel to follow medical recommendations. It suits readers reflecting on medication routines, follow-up visits, symptom monitoring, diet, activity, and related changes in care. As a treatment adherence questionnaire, it highlights areas that may feel manageable or difficult while keeping interpretation connected to current circumstances.
What This Assessment Measures
Here, adherence refers to stated readiness and willingness to follow medical recommendations in the situations described. Items address medication routines, side effects, symptom recording, appointments, tests, diet, activity, and lifestyle changes. The medication adherence assessment shows stated willingness, not verified past behavior.
The four scales are:
- Lifestyle Change (CC), 0-100, measures readiness for diet, activity, and harmful-habit changes: Low readiness 0-50; Moderate readiness 51-75; High readiness 76-100.
- Adherence to Medical Follow-Up, 0-100, measures readiness for appointments, examinations, and non-pharmacological advice: Low 0-50; Moderate 51-75; High 76-100.
- Medication Therapy Adherence (CD), 0-100, measures willingness to follow medication instructions, with lower scores indicating greater missed-dose or discontinuation risk: Low adherence 0-50; Moderate adherence 51-75; High adherence 76-100.
- Treatment Adherence, 0-100, measures willingness to combine medication, follow-up, and lifestyle changes; low scores indicate greater nonadherence risk: Low adherence 0-50; Moderate adherence 51-75; High adherence 76-100.
Methodology and Evidence Base
Each item uses six ordered response positions tailored to its wording. Respondents rate importance, difficulty, or likelihood of following a recommendation. The format captures perceived burden and stated intention across medication, monitoring, follow-up, and lifestyle decisions. Together, the items examine anticipated difficulty and willingness to carry out recommendations during long-term treatment, including medication, monitoring, appointments, and lifestyle changes over time.
The closest published instrument is QAA-25, described by Nikolaev and Skirdenko (2018) and updated in 2021. Those publications report construct and factor evidence for their QAA-25 versions, but do not establish clinical norms or identical digital scoring for this questionnaire.
Scores appear on 0-100 dimensions, but the ranges do not show how each response becomes points. Read the profile as a pattern: higher results indicate stronger stated willingness in that domain, while lower results can flag domains in which following care may be difficult.
Self-report remains affected by current health, memory, social desirability, and self-awareness. As a treatment compliance questionnaire, it is best used for focused reflection alongside the person’s treatment context, not as a complete record of adherence.
- Nikolayev N.A., Skirdenko Yu.P. Russian generic questionnaire for evaluation of compliance to drug therapy. Clinical Pharmacology and Therapy. 2018;27(1):74-78. In Russian.
- Nikolaev N.A., Skirdenko Yu.P., Balabanova A.A., Gorbenko A.V., Andreev K.A., Fedorin M.M., Livzan M.A., Chebanenko E.V., Usov G.M. The Scale of Quantitative Assessment Adherence to Treatment (QAA-25): Updating of Formulations, Constructive and Factor Validity and a Measure of Consent. Rational Pharmacotherapy in Cardiology. 2021;17(6):845-852. 10.20996/1819-6446-2021-12-12.
- Nikolaev N.A., Martynov A.I., Skirdenko Yu.P., Drapkina O.M., Livzan M.A., et al. The First Russian Consensus on the Quantitative Assessment of the Adherence to Treatment. Medical News of North Caucasus. 2019;14(3):424-434. 10.14300/mnnc.2019.14104.
Updated: